
WZZM
<img alt="" height="1" width="1" />
FDA Warns Against High-Dose Citalopram
MedPage Today
Citing increased risk of cardiac arrhythmias and a lack of therapeutic benefit associated with high doses of the selective serotonin reuptake inhibitor (SSRI) citalopram hydrobromide (Celexa), ...
FDA warns of heart risks with high doses of CelexaBusinessWeek
High Doses of SSRI Linked to Abnormal Heart RhythmMedscape
FDA warns of heart risks with high doses of CelexaNewsday (subscription)
all 98 news articles »
More...